Johnson & Johnson (JNJ) Tops Q3 EPS by 24c, Raises FY Guidance
Get Alerts JNJ Hot Sheet
Price: $146.72 -1.22%
Revenue Growth %: -13.4%
Financial Fact:
CASH DIVIDENDS PER SHARE: 0.8
Today's EPS Names:
FRSB, DGICA, UXIN, More
Revenue Growth %: -13.4%
Financial Fact:
CASH DIVIDENDS PER SHARE: 0.8
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
(Updated - October 19, 2021 6:28 AM EDT)
Johnson & Johnson (NYSE: JNJ) reported Q3 EPS of $2.60, $0.24 better than the analyst estimate of $2.36. Revenue for the quarter came in at $23.3 billion versus the consensus estimate of $23.74 billion.
GUIDANCE:
Johnson & Johnson sees 2021 EPS of $9.77-$9.82, versus the consensus of $9.66. Johnson & Johnson sees 2021 revenue of $94.1-94.6 billion, versus the consensus of $94.3 billion.
For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Airbus revenue rises, delivers 142 commercial aircraft in Q1
- CEMEX, S.A.B. de C.V. (CX) Tops Q1 EPS by 5c
- Bristol-Myers Squibb (BMY) stock slips despite earnings beat
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!